ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Clínica e Investigación en Arteriosclerosis has received its first journal Impact Factor (JCR) in 2023. Instructions for authors - Submit an article

"Methodological Notes": a new and important section in Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.424

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.435

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis

Los beneficios de medir el tamaño y el número de partículas de lipoproteínas para la predicción del riesgo cardiovascular: una revisión sistemática y un metaanálisis

Jose A. Quesadaa,b,1, Vicente Bertomeu-Gonzáleza,c,d,1, Domingo Orozco-Beltrána,b, Alberto Corderoc,d, Vicente F. Gil-Guilléna,b, Adriana López-Pinedaa,b,

Corresponding author

adriannalp@hotmail.com

Corresponding author.

, Rauf Nouni-Garcíaa,b, Concepción Carratalá-Munueraa,b

a Department of Clinical Medicine, Miguel Hernandez de Elche University, San Juan Campus, N-332, Km 87, 03550 Alicante, Spain

b Chair of Primary Care, Miguel Hernandez University, San Juan de Alicante, N-332, Km 87, 03550 Alicante, Spain

c Cardiology Section, San Juan de Alicante University Hospital, San Juan de Alicante, N-332, Alicante, Spain

d Biomedical Research Center in Cardiovascular Diseases Network (CIBERCV CB16/11/00420), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

Article information

ISSN: 25299123
Original language: English

DOI:10.1016/j.artere.2023.07.006

The statistics are updated each day